C16 Biosciences

About:

C16 Biosciences is a biotechnology company producing clean and safe alternatives to palm oil.

Website: https://www.c16bio.com

Twitter/X: c16bio

Top Investors: Elemental Impact, Y Combinator, UpHonest Capital, Pioneer Fund, Bill & Melinda Gates Foundation

Description:

C16 Biosciences is a biotechnology firm that uses microbiology to brew sustainable alternatives to palm oil. Utilizing its exclusive platform, the company is generating innovative ingredients without concessions for top global consumer goods manufacturers. Recently, they introduced the Palmless™ platform for sustainable ingredients, along with their inaugural biodesigned ingredient, Torula oil—a premium bioactive oil with clinically proven benefits for enhancing skin and hair health.

Total Funding Amount:

$33.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

2018-01-01

Contact Email:

website(AT)c16bio.com

Founders:

David Heller, Harry McNamara, Shara Ticku

Number of Employees:

11-50

Last Funding Date:

2024-01-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai